MONOCLONAL GAMMOPATHY

Clinical trials for MONOCLONAL GAMMOPATHY explained in plain language.

Never miss a new study

Get alerted when new MONOCLONAL GAMMOPATHY trials appear

Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Could a cancer drug stop myeloma before it starts?

Prevention Ongoing

This study is testing whether the drug daratumumab can prevent or delay the progression to active multiple myeloma in people with high-risk early-stage conditions (MGUS or smoldering myeloma). The trial involves 42 participants who have these conditions but do not yet have sympto…

Matched conditions: MONOCLONAL GAMMOPATHY

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention

Last updated Mar 31, 2026 12:12 UTC

MONOCLONAL GAMMOPATHY

Get alerted when new MONOCLONAL GAMMOPATHY trials appear

Could a cancer drug stop myeloma before it starts?